🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT01754363
Active, not recruiting Not applicable

Survivorship of Attune Primary Total Knee Prosthesis

NCT01754363 · tracked via the Priya Life Science USA tracker
Sponsor
DePuy International
Phase
Not applicable
Started
2013-02-01
Last updated
2026-08-28

Condition(s) studied

Noninflammatory Degenerative Joint Disease

Investigational drug(s) / intervention(s)

Attune Primary Total Knee Replacement

Attune Primary Total Knee Replacement: Patients will undergo a primary total knee replacement using one of the four configurations of the Attune knee (CR FB, CR RP, PS FB, PS RP).

Study summary

This post-marketing investigation will evaluate the long term (up to 15 years) survivorship of the Attune Primary Knee Prosthesis in patients with non-inflammatory degenerative joint disease. Data from Subjects who receive one of four knee configurations will be pooled to establish a contemporary dataset.

Eligibility

Sex
ALL
Min age
22 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Subject is male or female and between the ages of 22 and 75 years at the time of surgery, inclusive. * Subject was diagnosed with NIDJD. * Subject is a suitable candidate for cemented primary total knee arthroplasty using the devices described in this protocol with either resurfaced or non-resurfaced patellae. * Subject has given voluntary, written informed consent to participate in this clinical investigation and has authorized the transfer of his/her information to DePuy. * Subject is currently not bedridden. * Subject in the opinion of the Clinical Investigator, is able to understand this clinical investigation and is willing and able to perform all study procedure and follow-up visits and co-operate with investigational procedures. * Subject must be comfortable with speaking, reading and understanding questions and providing responses in an available translated language for the PROs in the protocol. * The devices specified in this protocol were implanted. Exclusion Criteria: * Subject is a woman who is pregnant or lactating. * Contralateral knee has already been enrolled in this study. * Subject had a contralateral amputation. * Previous partial knee replacement (unilateral, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy or primary TKA in affected knee. * Subject is currently experiencing radicular pain from the spine. * Subject has participated in an IDE/IND clinical investigation with an investigational product in the last three months. * Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims. * Subject is a known drug or alcohol abuser or has a psychological disorder that could affect their ability to complete patient reported questionnaires. * Subject was diagnosed with fibromyalgia that is currently being treated with prescription medication. * Subject has significant neurological or musculoskeletal disorders or disease that may adversely affect gait or weight bearing (e.g. muscular dystrophy, multiple sclerosis, Charcot disease). * Subject is suffering from inflammatory arthritis (e.g. rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosis, etc.). * Subject is not comfortable with speaking, reading, and understanding questions and providing responses in an available translated language for the PROs in the protocol. * Subject has a medical condition with less than 5 years of life expectancy.

Primary outcome measure(s)

Trial sites (27)

FacilityCityRegionStatus
Mayo Clinic Arizona Scottsdale Arizona
Orthopaedic Specialty Institute Orange California
Florida Research Associates, LLC DeLand Florida
Center for Hip and Knee Surgery Mooresville Indiana
University of Iowa Hospitals & Clinics Iowa City Iowa
Orthopedic One Columbus Ohio
OrthoNeuro New Albany Ohio
Penn State Hershey Bone & Joint Institute Hershey Pennsylvania
Texas Institute for Hip and Knee Surgery, LLC Austin Texas
Canberra Hospital-Trauma & Orthopaedic Research Unit Adelaide South Australia
Univ.-Klinik für Orthopädie Vienna Lower Austria
Krankenhaus der Barmherzigen Linz Upper Austria
Monica Camputs O.L.V. Middelares Antwerp Belgium
University of Western Ontario-Department of Orthopaedic Surgery London Ontario
Orthopädische Klinik für die Universität Regensburg Bad Abbach Bavaria
UniversitatsKlinikum Heidelberg Heidelberg Germany
Queen Mary Hospital Hong Kong Hong Kong
University Malaya Medical Centre Kuala Lumpur Malaysia
Ascot Hospital Auckland New Zealand
Singapore General Hospital-Dept of Orthopaedic Surgery Singapore Singapore
Seoul National University Boramae Hospital Seoul Dongjak-gu
Seoul National University Hospital Seoul South Korea
Queen Mary Hospital Dunfermline Fife
Robert Jones & Agnes Hunt Orthopaedic Hospital Gobowen Oswestry
New Royal Infirmary of Edinburgh Edinburgh Scotland
Princess Alexandria Hospital Harlow United Kingdom
Clifton Park NHS Treatment Centre York United Kingdom
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01754363 on ClinicalTrials.gov ↗ ← All trials in the USA